Analysis of the activating receptors and cytolytic function of human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation

European Journal of Immunology

Volumn 34, Issue 2, 2004, Pages 455-460

  Vitale, Chiara ^a,b   Chiossone, Laura ^b   Morreale, Giuseppe ^c   Lanino, Edoardo ^c   Cottalasso, Francesca ^b   Moretti, Sara ^c   Dini, Giorgio ^c   Moretta, Lorenzo ^b,c   Mingari, Maria Cristina ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

2B4; Activating receptor; Bone marrow transplantation; NK cell differentiation

Indexed keywords

CD16 ANTIGEN; CELL RECEPTOR; CYCLOSPORIN; ETOPOSIDE; FLUDARABINE; HLA ANTIGEN CLASS 1; MELPHALAN; MONOCLONAL ANTIBODY; NATURAL KILLER CELL RECEPTOR NKG2D; TACROLIMUS; THIOTEPA; FC RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CELL ACTIVITY; CELL DIFFERENTIATION; CELL MATURATION; CELL SURFACE; CELLULAR DISTRIBUTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; MELANOMA CELL; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WHOLE BODY RADIATION; BONE MARROW TRANSPLANTATION; CYTOLOGY; CYTOTOXICITY TEST; FEMALE; IMMUNOLOGY; MALE; PRESCHOOL CHILD;

ADOLESCENT; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; HUMANS; KILLER CELLS, NATURAL; MALE; RECEPTORS, IGG; RECEPTORS, IMMUNOLOGIC;

EID: 1642275490     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324668     Document Type: Article

References (30)

1. Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C. and Moretta, L., Receptors for HLA-class I molecules in human natural killer cells. Annu. Rev. Immunol. 1996. 14: 619-648.
2. Lanier, L. L., NK cell receptors. Annu. Rev. Immunol. 1998. 16: 359-393.
3. Long, E. O., Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 1999. 17: 875-904.
4. Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R. and Moretta, L., Activating receptors and co-receptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 2001. 19: 197-223.
5. Silva, M. R., Hoffman, R., Srour, E. F. and Ascensao, J. L., Generation of human natural killer cells from immature progenitors does not require marrow stromal cells. Blood 1994. 84: 841-846.
6. Mrozek, E., Anderson, P. and Caligiuri, M. A., Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood 1996. 87: 2632-2640.
7. Yu, H., Fehniger, T. A., Fuchshuber, P., Thiel, K. S., Vivier, E., Carson, W. E. and Caligiuri, M. A., Flt3-ligand promotes the generation of a distinct CD34+ human natural killer cell progenitor that responds to interleukin-15. Blood 1998. 92: 3647-3657.
8. Carayol, G., Robin, C., Bourhis, J. H., Bennaceur-Griscelli, A., Chouaib, S., Coulombel, L. and Cagnaird, A., NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions. Eur. J. Immunol. 1998. 28: 1991-2002.
9. Miller, J. S. and McCullar, V., Human natural killer cells with polyclonal lectin and immunoglobulin-like receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. Blood 2001. 98: 705-713.
10. Mingari, M. C., Vitale, C., Cantoni, C., Bellomo, R., Ponte, M., Schiavetti, F., Bertone, S., Moretta, A. and Moretta, L., Interleukin-15-induced maturation of human natural killer cells from early thymic precursors. Selective expression of CD94/NKG2A as the only HLA-class I-specific inhibitory receptor. Eur. J. Immunol. 1997. 27: 1734-1738.
11. Sivori, S., Falco, M., Marcenaro, E., Parolini, S., Biassoni, R., Bottino, C., Moretta, L. and Moretta, A., Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. Proc. Nat. Acad. Sci. USA 2002. 99: 4526-4531.
12. Morra, M., Howie, M., Simarro Grande, M., Saios, J., Wang, N., Wu, C., Engel, P. and Terhorst, C., X-linked lymphoproliferative disease: progressive immunodeficiency. Annu. Rev. Immunol. 2001. 19: 657-682.
13. Jacobs, R., Stoll, M., Stratmann, G., Leo, R., Link, H. and Schimdt, R. E., CD16-CD56+ natural killer cells after bone marrow transplantation. Blood 1992. 12: 3239-3244.
14. Vitale, C., Pitto, A., Benvenuto, F., Ponte, M., Bellomo, R., Frassoni, F., Mingari, M. C., Bacigalupo, A. and Moretta, L., Phenotypic and functional analysis of the HLA-class I-specific inhibitory receptors of natural killer cells isolated from peripheral blood of patients undergoing bone marrow transplantation from matched unrelated donors. Hematol. J. 2000. 1: 136-144.
15. Shilling, H. G., McQueen, K. L., Shizuru, J. A., Negrin, R. S. and Parham, P., Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood 2003. 101: 3730-3740.
16. Robertson, M. J. and Ritz, J., Biology and clinical relevance of human natural killer cells. Blood 1990. 76: 2421-2438.
17. Giebel, S., Locatelli, F., Lamparelli, T., Velardi, A., Davies, S., Frumento, G., Maccario, R., Bonetti, F., Woinar, J., Martinetti, M. et al., Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 2003. 102: 814-819.
18. Ruggeri, L., Capanni, M., Casacci, M., Volpi, I., Tosti, A., Perruccio, K., Urbani, E., Negrin, M. F., Martelli, M. F. and Velardi, A., Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999. 94: 333-339.
19. Ruggeri, L., Capanni, M., Urbani, E., Urbani, E., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia D., Frassoni, F., Aversa, F. et al., Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002. 295: 2097-2100.
20. Zutter, M. M., Martin, P. J., Sale, G. E., Shulman, H. M., Fisher, L., Thomas, E. D. and Durnam, D. M. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 1988. 72: 520-529.
21. Shapiro, R. S., McClain, K., Frizzera, G., Gajl-Peczalska, K. J., Kersey, J. H., Blazar, B. R., Arthur, D. C., Patton, D. F., Greenberg, J. S., Burke, B. et al., Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988. 71: 1234-1244.
22. Deeg, H. J. and Socié, G., Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood 1998. 91: 1833-1844.
23. Orazi, A., Hromas, R. A., Neimann, R. S., Greiner, T. C., Lee, C. H., Rubin, L., Haskins, S., Heerema, N. A., Gharpure, V., Abonour, R. et al., Post-transplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with high incidence of adverse histologic and immunobiologic features. Am. J. Clin. Pathol. 1997. 107: 419-429.
24. Parolini, S., Bottino, C., Falco, M., Augugliaro, R., Giliani, S., Franceschini, R., Ochs, H. D., Wolf, H., Bonnefoy, J. Y., Biassoni, R. et al., X-linked lymphoproliferative disease: 2B4 molecule displaying inhibitory rather than activating function are responsible for the inability of NK cells to kill EBV-infected cells. J. Exp. Med. 2000. 192: 337-346.
25. Curtis, R. E., Travis, L. B., Rowlins, P. A., Socié, G., Kingma, D. V., Banks, P. M., Jaffe, E. S., Sale, G. E., Horovitz, M. M., Witherspoon, R. P. et al., Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 1999. 94: 2208-2216.
26. Juvonem, E., Aalto, S. M., Tarkkanen, J., Volin, L., Mattila, P. S., Knuutila, S., Ruutu, T. and Hedman, K., High incidence of PTLD after non-T-cell-depleted allogeneic hematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment. Bone Marrow Transplant. 2003. 32: 97-102.
27. Sivori, S., Vitale, M., Morelli, L., Sanseverino, L., Augugliaro, R., Bottino, C., Moretta, L. and Moretta, A., p46 a novel natural killer cell-specific surface molecule which mediates cell activation. J. Exp. Med. 1997. 186: 1129-1136.
28. Pende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Marcenaro, E., Accame, L., Malaspina, A., Biassoni, R., Bottino, C. et al., Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med. 1999. 190: 1505-1516.
29. Sivori, S., Vitale, M., Bottino, C., Marcenaro, E., Sanseverino, L., Parolina, S., Moretta, L. and Moretta, A., CD94 functions as a natural killer cell inhibitory receptor for different HLA-class I alleles. Identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur. J. Immunol. 1996. 26: 2487-2492.
30. Vitale, M., Bottino, C., Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R., Moretta, L. and Moretta, A., NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells is involved in non-MHC restricted tumor cell lysis. J. Exp. Med. 1998. 187: 2065-2072.